Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
GAAD Medical Research Institute Inc. |
---|---|
Information provided by: | GAAD Medical Research Institute Inc. |
ClinicalTrials.gov Identifier: | NCT00675155 |
A stroke is a sudden loss of brain function. It is caused by the interruption of flow of blood to the brain (ischemic stroke) or the rupture of blood vessels in the brain (hemorrhagic stroke). This study will investigate the use of far infrared radiation for stroke rehabilitation.
Condition | Intervention | Phase |
---|---|---|
Stroke |
Radiation: Far Infrared Radiation |
Phase I |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study |
Official Title: | Phase 1 Study to Determine the Efficacy of Using Far Infrared Radiation for Stroke Rehabilitation |
Estimated Enrollment: | 10 |
Study Start Date: | May 2008 |
Estimated Study Completion Date: | June 2010 |
Estimated Primary Completion Date: | May 2010 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Experimental
Radiation: Far Infrared Radiation (5μm to 20μm wavelength)
|
Radiation: Far Infrared Radiation
Radiation: Far Infrared Radiation (5μm to 20μm wavelength) Far Infrared radiation for 30 to 40 minutes per treatment session.
|
A stroke is a sudden loss of brain function. The interruption of blood flow or the rupture of blood vessels causes brain cells (neurons) in the affected area to die. The effects of a stroke depend on where the brain was injured, as well as how much damage occurred. A stroke can impact any number of areas including your ability to move, see, remember, speak, reason and read and write.
It is hereby postulated that irradiation using far infrared, with wavelength between 5 to 20 microns, of the central nervous system, the endocrine system and the whole body could prevent, control, manage or possibly lead to complete rehabilitation of people with stroke.
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Canada, Ontario | |
The Centre for Incurable Diseases | |
Toronto, Ontario, Canada, M4V 1L5 |
Principal Investigator: | Ken Nedd, M.D. | GAAD Medical Research Institute Inc. |
Responsible Party: | GAAD Medical Research Institute Inc. ( Dr. Kwasi Donyina/Founder and President ) |
Study ID Numbers: | GAAD-SR-CTP1 |
Study First Received: | May 6, 2008 |
Last Updated: | January 2, 2009 |
ClinicalTrials.gov Identifier: | NCT00675155 |
Health Authority: | Canada: Health Canada; United States: Food and Drug Administration |
Apoplexy Cerebral Stroke Cerebrovascular Accident |
Cerebrovascular Accident, Acute Cerebrovascular Apoplexy Cerebrovascular Stroke |
Cerebral Infarction Stroke Vascular Diseases Brain Ischemia Central Nervous System Diseases |
Ischemia Brain Infarction Brain Diseases Infarction Cerebrovascular Disorders |
Nervous System Diseases Cardiovascular Diseases |